DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jim Cramer's - 5 Jim Cramer - 5 Jim - 5 Peter Arduini - 3 We're - 3 Arduini - 2 GEHC - 2 Martin Schutt - 2
Top related locs:
China U.S Jena , Germany Eisai Boston Macao Asia SWK
Top related orgs:
GE Healthcare - 5 CNBC - 5 Management - 4 Getty - 4 LSEG - 3 General Electric - 3 Philips - 3 Siemens - 3

Search resuls for: "GE Healthcare YTD"


6 mentions found


☆ We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts
  + stars: | 2024-10-30 | by ( Zev Fima | ) www.cnbc.com   time to read: +9 min
Organic revenue growth of 1% matched expectations. Management raised the midpoint of full-year earnings guidance despite the continued in weakness in China that has been hampering top-line organic growth. Bottom Line Results were mixed, but it comes as no surprise that the quarter was negatively impacted by weakness in China. The team continues to deliver for customers and we've seen PDx reports seven quarters of high-single-digit or double-digit organic revenue growth." Pharmaceutical Diagnostics (PDx) segment — used in radiology and nuclear medicine to deliver more precise diagnoses — was particularly strong, delivering segment revenue growth of 7% organically.
Persons: Peter Arduini, Arduini, We're, James Saccaro, Saccaro, GEHC, Jim Cramer's, Jim Cramer, Jim, Martin Schutt Organizations: GE Healthcare, Revenue, LSEG, Management, Pharmaceutical Diagnostics, General Electric, Philips, Siemens, U.S . Food, Drug Administration, GE Healthcare's, Care Solutions, CNBC, Getty Locations: China, U.S, Jena , Germany
☆ GEHC gives reasons to look beyond temporary China woes and shares reverse higher
  + stars: | 2024-07-31 | by ( Zev Fima | ) www.cnbc.com   time to read: +9 min
GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. Organic revenue growth was 1%. We saw a continued acceleration of Vizamyl doses delivered in the U.S. in the second quarter. This is still a small contributor to sales growth but gives us optimism about its sales potential over the next few years." As a result, we're lowering our total company full-year organic revenue growth guidance."
Persons: Philips, It's, Eli Lilly, GEHC, —, Jay Saccaro, We're, Arduini, Peter Arduini, Jim Cramer's, Jim Cramer, Jim, Pavlo Gonchar Organizations: GE Healthcare, Management, Revenue, LSEG, General Electric, Philips, Siemens, Club, GE Healthcare YTD, GE Healthcare's, Care Solutions, Pharmaceutical Diagnostics, U.S, CNBC, Lightrocket, Getty Locations: China, Eisai, U.S
☆ Here are 5 stocks that are buys right here, right now
  + stars: | 2024-05-30 | by ( Jim Cramer | ) www.cnbc.com   time to read: +5 min
Let's say you just joined the Club, and you are trying to figure out which stocks we think are buyable right now, right here. The question is: Which stocks would I buy right now? In fact, we added some more shares to the Club portfolio Wednesday. WYNN YTD mountain Wynn Resorts YTD I would most certainly buy the stock of Wynn Resorts . (Jim Cramer's Charitable Trust is long GEHC, HON, WYNN, SWK, F. See here for a full list of the stocks.)
Persons: WYNN, Boston —, Wynn, Decker, That's, Neil Kashkari, Stanley Black, Jim Cramer's, Jim Cramer, Jim, Jim Cramer Rob Kim Organizations: Club, GE Healthcare, Honeywell, DuPont, Raytheon, United Technologies, Electric, Wynn, Wynn Resorts, Vegas, Stanley, Ford, CNBC Locations: Boston, Macao, Asia, SWK
☆ GE Healthcare's disappointing first quarter offers both a lesson and an opportunity
  + stars: | 2024-04-30 | by ( Jeff Marks | ) www.cnbc.com   time to read: +10 min
GE Healthcare shares sank Tuesday after the company's first-quarter sales and profits fell slightly short of the Wall Street consensus. GE Healthcare Why we own it : GE Healthcare is the global leader in medical imaging, diagnostics, and digital solutions in health care. That's what we have to say about this GE Healthcare quarter. This contributed to some of the softness in the first quarter quarter. The GE Healthcare scanner is called the Revolution CT. Martin Schutt | picture alliance | Getty Images
Persons: didn't, GE Healthcare's, —, it's, Peter Arduini, Jim Cramer's, Jim Cramer, Jim, Martin Schutt Organizations: GE Healthcare, LSEG, General Electric, Philips, Siemens, GE Healthcare YTD, GE, Management, Alzheimer's, CNBC, Getty Locations: China, Covid, Jena , Germany
☆ We're buying more of 2 stocks, deploying some of our cash pile in an oversold market
  + stars: | 2023-08-21 | by ( Jeff Marks Jim Cramer | Jeff Marks | Jim Cramer | ) www.cnbc.com   time to read: +4 min
We're putting a little more of our big cash position to work Monday into the oversold market. As a reminder, anything more negative than minus 4% indicates a market that is oversold. SWK YTD mountain Stanley Black & Decker YTD performance We're also adding to our position in Stanley Black & Decker , the industrial tools and household hardware manufacturer that's turning itself around. (Jim Cramer's Charitable Trust is long GEHC, SWK. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: Stanley Black, Decker, Jim Cramer's, Wells, Wells Fargo, SWK, We're, Stanley, Jim Cramer, Jim Organizations: GE Healthcare, Stanley, GEHC, SWK, Management, Wall, CNBC, New York Stock Exchange, View Press, Getty Locations: Wells Fargo, New York
☆ We're starting a new position in one of the Big 3 global medical imaging and diagnostics companies
  + stars: | 2023-05-17 | by ( Jeff Marks Jim Cramer | Jeff Marks | Jim Cramer | ) www.cnbc.com   time to read: +7 min
We're initiating a position in GE Healthcare (GEHC), buying 325 shares at roughly $79 each. GE Healthcare is the global leader in medical imaging, diagnostics, and digital solutions. GE Healthcare is one of the global leaders in Precision Diagnostics with an industry-leading injectable pharmaceutical portfolio in contrast media and molecular imaging. GE Healthcare is one of a few companies that offer a full suite of products and solutions to support patients. GEHC YTD mountain GE Healthcare YTD performance Analysts see GE Healthcare growing EPS to $4.33 in 2024, about a 15% increase from this year's outlook.
0 next >>
Total: 6